The mechanism of activation of MEK1 by B-Raf and KSR1

Ryan C Maloney1, Mingzhen Zhang2, Yonglan Liu1

  • 1Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD, 21702, USA.

Insights

Molecular dynamics simulations reveal MEK1's proline-rich loop dictates activation loop phosphorylation. Distinct B-Raf/MEK1 and KSR1/MEK1 interactions explain differing MEK1 activation mechanisms in cell signaling.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Biochemistry

Background:

  • Ras/Raf/MEK/ERK signaling is crucial for cellular processes.
  • Mechanisms of MEK1 activation by B-Raf and KSR1 remain incompletely understood.
  • Distinct roles of B-Raf/MEK1 and KSR1/MEK1 complexes in MEK1 activation require clarification.

Purpose of the Study:

  • To elucidate the mechanistic details of MEK1 activation by B-Raf and KSR1.
  • To clarify the distinct contributions of B-Raf/MEK1 and KSR1/MEK1 complexes to MEK1 activation.
  • To resolve ambiguities regarding the role of KSR1 in signal transduction.

Main Methods:

  • Molecular dynamics simulations were employed.
  • Analysis focused on protein-protein interactions within signaling complexes.
  • Key residues and structural elements influencing MEK1 activation were investigated.

Main Results:

  • MEK1's proline-rich (P-rich) loop is critical for activation loop (A-loop) phosphorylation.
  • In B-Raf/MEK1, A-loop interactions differ between inactive and active states, modulating MEK1 A-loop flexibility and phosphorylation.
  • Specific residues (e.g., B-Raf Arg662) and structural features (e.g., KSR1 Ala826) dictate differential MEK1 activation.

Conclusions:

  • The MEK1 P-rich loop and A-loop dynamics are central to B-Raf and KSR1 mediated activation.
  • Structural differences between B-Raf and KSR1 directly impact MEK1 activation efficiency.
  • KSR1 has the potential to function as an active kinase, similar to B-Raf, under specific structural configurations.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.6K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
10.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K